Schonberger L B, Kaplan J, Kim-Farley R, Moore M, Eddins D L, Hatch M
Rev Infect Dis. 1984 May-Jun;6 Suppl 2:S424-6. doi: 10.1093/clinids/6.supplement_2.s424.
The changing annual vaccination status of the population and the greater than 1,000-fold drop in reported annual incidence of paralytic poliomyelitis between the early 1950s and early 1970s indicate that the control of poliomyelitis in the United States must be attributed to the use of both the inactivated poliovirus vaccine and oral poliovirus vaccine. The containment, in 1972 and 1979, of rare epidemics in poorly vaccinated subpopulations and the existence of only three reported cases of paralytic poliomyelitis clearly attributable to wild poliovirus in the last three years document a major triumph for public health. The continuing occurrence of vaccine-associated paralysis (six or seven reported cases per year, 1980-1982) indicates the necessity, despite the accomplishments, for continued review of the current vaccination strategy.
20世纪50年代初至70年代初，人群年度疫苗接种状况不断变化，同时报告的麻痹性脊髓灰质炎年发病率下降了1000多倍，这表明美国脊髓灰质炎的控制必须归功于灭活脊髓灰质炎病毒疫苗和口服脊髓灰质炎病毒疫苗的使用。1972年和1979年，疫苗接种率低的亚人群中罕见疫情得到控制，且过去三年仅报告了三例明确由野生脊髓灰质炎病毒引起的麻痹性脊髓灰质炎病例，这些都证明了公共卫生取得的重大胜利。疫苗相关麻痹的持续发生（1980 - 1982年每年报告6或7例）表明，尽管已取得成就，但仍有必要持续审查当前的疫苗接种策略。
